BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/1/2016 11:49:00 AM | Browse: 1676 | Download: 2323
Publication Name World Journal of Gastrointestinal Pharmacology and Therapeutics
Manuscript ID 26325
Country United States
ISSN 2150-5349 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Topic Highlights
Article Title Management of pain in chronic pancreatitis with emphasis on exogenous pancreatic enzymes
Manuscript Source Invited Manuscript
All Author List Paul M Hobbs, William G Johnson and David Y Graham
Funding Agency and Grant Number
Corresponding Author David Y Graham, MD, Department of Medicine, Michael E DeBakey Veterans Affairs Medical Center, Baylor College of Medicine, RM 3A-318B (111D), 2002 Holcombe Boulevard, Houston, TX 77030, United States. dgraham@bcm.edu
Key Words Pancreatic enzyme replacement therapy; Chronic pancreatitis; Pancreatic insufficiency; Protease; Clinical trials; Trypsin; Fat malabsorption; Pain
Core Tip Pancreatic enzyme replacement therapy has long been used as a non-invasive treatment for chronic pancreatic pain. Enzyme therapy aims to restore feedback inhibition of pancreatic secretion to lessen pain caused by pancreatic ductal hypertension, increased pancreatic interstitial pressure, and pancreatic ischemia. Although enzyme therapy may play a role the key is individualization of therapy based on disease etiology and severity. Here we review the literature regarding the efficacy of enzyme therapy and the evidence gathered for an entero-pancreatic feedback loop. We also describe alternative strategies for improving pain therapy including using uncoated enzymes with gastric acid suppression.
Publish Date 2016-08-01 11:49
Citation Hobbs PM, Johnson WG, Graham DY. Management of pain in chronic pancreatitis with emphasis on exogenous pancreatic enzymes. World J Gastrointest Pharmacol Ther 2016; 7(3): 370-386
URL http://www.wjgnet.com/2150-5349/full/v7/i3/370.htm
DOI http://dx.doi.org/10.4292/wjgpt.v7.i3.370
Full Article (PDF) WJGPT-7-370.pdf
Full Article (Word) WJGPT-7-370.doc